Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
出版年份 2023 全文链接
标题
Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
作者
关键词
-
出版物
PHARMACEUTICAL RESEARCH
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-01-13
DOI
10.1007/s11095-023-03469-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
- (2022) Jiangling Peng et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Pain response to Cannabidiol in opioid-induced hyperalgesia, Acute Nociceptive pain and Allodynia By using a model mimicking acute pain in healthy adults in a randomized trial (CANAB II)
- (2022) Markus Dieterle et al. PAIN
- The Transdermal Delivery of Therapeutic Cannabinoids
- (2022) Haleh Mahmoudinoodezh et al. Pharmaceutics
- Enhanced Stability and Oral Bioavailability of Cannabidiol in Zein and Whey Protein Composite Nanoparticles by a Modified Anti-Solvent Approach
- (2022) Ce Wang et al. Foods
- Plasma Pharmacokinetics of Cannabidiol Following Oral Administration of Cannabidiol Oil to Dairy Calves
- (2022) Kelsey Meyer et al. Frontiers in Veterinary Science
- Recent advances in drug delivery to the central nervous system by inhalation
- (2022) Waiting Tai et al. Expert Opinion on Drug Delivery
- Pharmacokinetics, Safety, and Synovial Fluid Concentrations of Single- and Multiple-Dose Oral Administration of 1 and 3 mg/kg Cannabidiol in Horses
- (2022) Alicia F. Yocom et al. JOURNAL OF EQUINE VETERINARY SCIENCE
- Drug Nanocrystals: Focus on Brain Delivery from Therapeutic to Diagnostic Applications
- (2022) Elide Zingale et al. Pharmaceutics
- Advances and future perspectives in epithelial drug delivery
- (2022) Yousuf Mohammed et al. ADVANCED DRUG DELIVERY REVIEWS
- Pharmacokinetics of Cannabidiol Following Intranasal, Intrarectal, and Oral Administration in Healthy Dogs
- (2022) Dakir Polidoro et al. Frontiers in Veterinary Science
- The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence
- (2022) Jonathon C. Arnold et al. CTS-Clinical and Translational Science
- Promising Nanocarriers to Enhance Solubility and Bioavailability of Cannabidiol for a Plethora of Therapeutic Opportunities
- (2022) Lucia Grifoni et al. MOLECULES
- Cannabidiol as a Treatment for Craving and Relapse in Individuals with Cocaine Use Disorder: a Randomized Placebo‐Controlled Trial
- (2021) Violaine Mongeau‐Pérusse et al. ADDICTION
- Evaluation of the Effect of Cannabidiol on Naturally Occurring Osteoarthritis-Associated Pain: A Pilot Study in Dogs
- (2021) Sebastian Mejia et al. JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION
- Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma
- (2021) Alexandre Vallée et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action
- (2021) Marcin Ożarowski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain
- (2021) Bronwyn Bebee et al. MEDICAL JOURNAL OF AUSTRALIA
- Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial
- (2021) Ingrid E. Scheffer et al. EPILEPSIA
- Long‐term safety and efficacy of add‐on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long‐term open‐label extension trial
- (2021) Anup D. Patel et al. EPILEPSIA
- Inclusion complexes of cannabidiol with β-cyclodextrin and its derivative: Physicochemical properties, water solubility, and antioxidant activity
- (2021) Hang Li et al. JOURNAL OF MOLECULAR LIQUIDS
- Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study
- (2021) Orrin Devinsky et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations
- (2021) Lyndsey L. Anderson et al. Scientific Reports
- Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials
- (2021) Li Wang et al. BMJ-British Medical Journal
- The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies
- (2021) Antonella Fattorusso et al. Frontiers in Neurology
- A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study
- (2021) Luis Vitetta et al. INFLAMMOPHARMACOLOGY
- Long‐term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open‐label extension trial
- (2021) Elizabeth A. Thiele et al. EPILEPSIA
- Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol
- (2021) Lie Yun Kok et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Lipid-based formulations to increase cannabidiol bioavailability: In vitro digestion tests, pre-clinical assessment and clinical trial
- (2021) Manuel A.A. De Prá et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Plasma and joint tissue pharmacokinetics of two doses of oral cannabidiol oil in guinea pigs ( Cavia porcellus )
- (2021) Alexa P. Spittler et al. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS
- Pharmacokinetic Evaluation of a Cannabidiol Supplement in Horses
- (2021) Megan R. Williams et al. JOURNAL OF EQUINE VETERINARY SCIENCE
- The Effect of Medium Chain and Long Chain Triglycerides Incorporated in Self-Nano Emulsifying Drug Delivery Systems on Oral Absorption of Cannabinoids in Rats
- (2020) Dvora Izgelov et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cannabinoids, Blood–Brain Barrier, and Brain Disposition
- (2020) Fabrizio Calapai et al. Pharmaceutics
- Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications
- (2020) Emilio Perucca et al. CNS DRUGS
- A Phase I Trial of the Safety, Tolerability, and Pharmacokinetics of Cannabidiol Administered as Single‐dose Oil Solution and Single and Multiple doses of a Sublingual Wafer in Healthy Volunteers
- (2020) Adele Hosseini et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The Essential Medicinal Chemistry of Cannabidiol (CBD)
- (2020) Kathryn M. Nelson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oral Transmucosal Cannabidiol Oil Formulation as Part of a Multimodal Analgesic Regimen: Effects on Pain Relief and Quality of Life Improvement in Dogs Affected by Spontaneous Osteoarthritis
- (2020) Federica Alessandra Brioschi et al. Animals
- Towards Better Delivery of Cannabidiol (CBD)
- (2020) Sophie Anne Millar et al. Pharmaceuticals
- Chronic administration of synthetic cannabidiol induces antidepressant effects involving modulation of serotonin and noradrenaline levels in the hippocampus
- (2020) Melkamu Alemu Abame et al. NEUROSCIENCE LETTERS
- Add-On Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex
- (2020) Elizabeth A. Thiele et al. JAMA Neurology
- Dry Powder for Pulmonary Delivery: A Comprehensive Review
- (2020) Birendra Chaurasiya et al. Pharmaceutics
- Design and Application in Delivery System of Intranasal Antidepressants
- (2020) Jingying Xu et al. Frontiers in Bioengineering and Biotechnology
- Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
- (2020) María S. García-Gutiérrez et al. Biomolecules
- Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
- (2019) Yasmin L. Hurd et al. AMERICAN JOURNAL OF PSYCHIATRY
- Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
- (2019) Sneham Tiwari et al. International Journal of Nanomedicine
- Pharmacotherapy for Cocaine Use Disorder—a Systematic Review and Meta-analysis
- (2019) Brian Chan et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Pharmacokinetics of oral and intravenous cannabidiol and its antidepressant-like effects in chronic mild stress mouse model
- (2019) Chen Xu et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- A meta-opinion: cannabinoids delivered to oral mucosa by a spray for systemic absorption are rather ingested into gastro-intestinal tract: the influences of fed / fasting states
- (2019) Constantin Itin et al. Expert Opinion on Drug Delivery
- A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb® Formulation Technology Improving the Oral Bioavailability of Cannabidiol in Healthy Subjects
- (2019) Katharina Knaub et al. MOLECULES
- Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
- (2019) Lyndsey L. Anderson et al. EPILEPSIA
- Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis
- (2019) Tory R Spindle et al. JOURNAL OF ANALYTICAL TOXICOLOGY
- A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment
- (2019) Bola Tayo et al. CLINICAL PHARMACOKINETICS
- GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol
- (2018) Alyssa S. Laun et al. ACTA PHARMACOLOGICA SINICA
- Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal
- (2018) Chandni Hindocha et al. ADDICTION
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Pharmacokinetics and the Pharmacodynamics of Cannabinoids
- (2018) C.J. Lucas et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Use of spacers for patients treated with pressurized metered dose inhalers: focus on the VENTOLIN™ Mini Spacer
- (2018) Gregor Anderson et al. Expert Opinion on Drug Delivery
- Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabis Addiction and the Brain: a Review
- (2018) Amna Zehra et al. Journal of Neuroimmune Pharmacology
- The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
- (2018) Manoela V. Fogaça et al. NEUROPHARMACOLOGY
- Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle
- (2018) Gustavo Gonzalez-Cuevas et al. NEUROPSYCHOPHARMACOLOGY
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
- (2018) Douglas L. Boggs et al. PSYCHOPHARMACOLOGY
- Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay
- (2018) L. Cuñetti et al. TRANSPLANTATION PROCEEDINGS
- Cannabinoid Delivery Systems for Pain and Inflammation Treatment
- (2018) Natascia Bruni et al. MOLECULES
- Management of common adverse effects of antipsychotic medications
- (2018) T. Scott Stroup et al. World Psychiatry
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- (2018) Lesley Taylor et al. CNS DRUGS
- ∆9-Tetrahydrocannabinol, a major marijuana component, enhances the anesthetic effect of pentobarbital through the CB1 receptor
- (2018) Toshiyuki Kimura et al. Forensic Toxicology
- Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
- (2018) Ila M. Linares et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
- (2018) Sophie A. Millar et al. Frontiers in Pharmacology
- Pharmacology of cannabinoids in the treatment of epilepsy
- (2017) Tyler E. Gaston et al. EPILEPSY & BEHAVIOR
- The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group
- (2017) Harneet Hundal et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis
- (2017) Holly T. Philpott et al. PAIN
- The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptors
- (2017) T. Bakas et al. PHARMACOLOGICAL RESEARCH
- Cannabidiol: State of the art and new challenges for therapeutic applications
- (2017) Simona Pisanti et al. PHARMACOLOGY & THERAPEUTICS
- Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
- (2017) Eva Martínez-Pinilla et al. Frontiers in Pharmacology
- Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
- (2017) Antonio W. Zuardi et al. Frontiers in Pharmacology
- Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex
- (2016) Evan J. Hess et al. EPILEPSIA
- Barriers to Post-Acute Care for Patients on Opioid Agonist Therapy; An Example of Systematic Stigmatization of Addiction
- (2016) Sarah E. Wakeman et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice
- (2016) Natalia Brzozowska et al. PeerJ
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox–Gastaut syndrome
- (2015) Shaun A. Hussain et al. EPILEPSY & BEHAVIOR
- Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis
- (2015) D.C. Hammell et al. EUROPEAN JOURNAL OF PAIN
- Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- (2015) Matthew W. Elmes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Critical Role of Mast Cells and Peroxisome Proliferator–Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo
- (2015) Venkatesh L. Hegde et al. JOURNAL OF IMMUNOLOGY
- Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data
- (2015) Michael H. Andreae et al. JOURNAL OF PAIN
- Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine
- (2015) Luciano Rezende Vilela et al. MEDIATORS OF INFLAMMATION
- Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
- (2015) Margaret Haney et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol as a Potential Treatment for Anxiety Disorders
- (2015) Esther M. Blessing et al. Neurotherapeutics
- Molecular Targets of Cannabidiol in Neurological Disorders
- (2015) Clementino Ibeas Bih et al. Neurotherapeutics
- A systematic review of the antipsychotic properties of cannabidiol in humans
- (2015) Tabitha A. Iseger et al. SCHIZOPHRENIA RESEARCH
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- (2014) Marcos Hortes N Chagas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Levetiracetam Rectal Administration in Healthy Dogs
- (2014) R.K. Peters et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice
- (2014) David Cheng et al. PSYCHOPHARMACOLOGY
- Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal
- (2014) David J. Allsop et al. JAMA Psychiatry
- Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings
- (2013) Celia J.A. Morgan et al. ADDICTIVE BEHAVIORS
- Oral transmucosal drug delivery for pediatric use
- (2013) Jenny K.W. Lam et al. ADVANCED DRUG DELIVERY REVIEWS
- Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors
- (2013) Francisco Espejo-Porras et al. NEUROPHARMACOLOGY
- Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+Cells Through PPARγ Involvement
- (2013) Caterina Scuderi et al. PHYTOTHERAPY RESEARCH
- Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents
- (2012) Massimo Nabissi et al. CARCINOGENESIS
- A potential role for GPR55 in gastrointestinal functions
- (2012) Rudolf Schicho et al. CURRENT OPINION IN PHARMACOLOGY
- Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
- (2012) Wei Xiong et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis
- (2012) Aitor G. Granja et al. Journal of Neuroimmune Pharmacology
- Intranasal Treatment of Central Nervous System Dysfunction in Humans
- (2012) Colin D. Chapman et al. PHARMACEUTICAL RESEARCH
- Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
- (2012) A. C. Campos et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
- (2011) A. M. Martin-Moreno et al. MOLECULAR PHARMACOLOGY
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
- (2011) Mateus M Bergamaschi et al. NEUROPSYCHOPHARMACOLOGY
- Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour
- (2011) Serena Deiana et al. PSYCHOPHARMACOLOGY
- Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes
- (2010) Luciano De Petrocellis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers
- (2010) Kalpana S. Paudel et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors
- (2010) Bogna Ignatowska-Jankowska et al. NEUROSCIENCE LETTERS
- Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)
- (2010) Jaime E. C. Hallak et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- 5-HT1Areceptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
- (2009) Leonardo B.M. Resstel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances
- (2009) Y. Ren et al. JOURNAL OF NEUROSCIENCE
- The Nonpsychotropic Cannabinoid Cannabidiol Modulates and Directly Activates Alpha-1 and Alpha-1-Beta Glycine Receptor Function
- (2009) Jörg Ahrens et al. PHARMACOLOGY
- The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo
- (2009) L. S. Whyte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- TRPV2 Is Activated by Cannabidiol and Mediates CGRP Release in Cultured Rat Dorsal Root Ganglion Neurons
- (2008) N. Qin et al. JOURNAL OF NEUROSCIENCE
- Plant-Derived Cannabinoids Modulate the Activity of Transient Receptor Potential Channels of Ankyrin Type-1 and Melastatin Type-8
- (2008) L. De Petrocellis et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders
- (2008) Caterina Scuderi et al. PHYTOTHERAPY RESEARCH
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
- (2007) G Esposito et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search